Literature DB >> 12963517

Pregnancy complicated by heart disease: a review of Canadian experience.

M sermer1, J Colman, S Siu.   

Abstract

The physiological adaptations to pregnancy can potentially worsen the prognosis in women whose pregnancy is complicated by heart disease. A comprehensive systematic approach to risk identification is desirable. The ability to predict a subgroup of women that are at a particularly increased risk of pregnancy-related complications can enhance the obstetric care we provide to this population. A retrospective review of 276 pregnancies associated with pre-existing heart disease was undertaken in three Toronto teaching institutions. During the course of the pregnancy, 45 (18%) of 252 completed gestations were complicated by adverse cardiovascular events (congestive heart failure, arrhythmia and stroke). Poor maternal functional class or cyanosis, myocardial dysfunction, left heart obstruction, prior arrhythmia and prior cardiac events were predictive of maternal cardiac complications. These predictors were converted into a point score. If a point score was 0, 1 or more than 1, the risk of a given patient running into cardiovascular complication was 3%, 30% and 66%, respectively. The Canadian Prospective Multicenter Study offered the validation of this prediction rule. In this study, 13 centres recruited prospectively 599 patients with completed gestations. Similar factors were identified in their ability to predict adverse cardiac events. In addition, neonatal complications (20% of pregnancies) were associated with poor functional class or cyanosis, left heart obstruction, anticoagulation, smoking and multiple gestation. A sample of this prospective cohort (302 pregnancies) was compared to 572 matched pregnancies with no underlying heart disease. The neonatal complication rate was higher in the study group when compared to controls, 18% versus 7%, respectively. The highest neonatal complication rate (33%) was seen in gravidas with underlying heart disease who had previously identified cardiac risk factors, were at both extremes of reproductive age, had obstetrical risk factors, smoked or received anticoagulants. Both maternal and neonatal morbidity are increased significantly in gravidas with pre-existing heart disease, although mortality is low. Factors that place the mother and the neonate at risk can be identified before pregnancy. This allows informed counselling and development of a patient-specific management plan.

Entities:  

Mesh:

Year:  2003        PMID: 12963517     DOI: 10.1080/0144361031000153492

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  5 in total

Review 1.  The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors:  Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

2.  Emergency therapy of maternal and fetal arrhythmias during pregnancy.

Authors:  Hans-Joachim Trappe
Journal:  J Emerg Trauma Shock       Date:  2010-04

3.  Fetomaternal outcome of pregnancy with Mitral stenosis.

Authors:  Nazia Ahmed; Hafeeza Kausar; Lubna Ali
Journal:  Pak J Med Sci       Date:  2015       Impact factor: 1.088

4.  Emergency cesarean delivery in a parturient who had an intractable paroxysmal supraventricular tachycardia -A case report-.

Authors:  Kyoung Ok Kim; Eun-Jung Chang; Jin Han; Hun Cho
Journal:  Korean J Anesthesiol       Date:  2012-10-12

5.  Outcomes of pregnancy in women with congenital heart disease: a single center experience in Korea.

Authors:  Young Bin Song; Seung Woo Park; Jun Hyung Kim; Dae-Hee Shin; Sung Won Cho; Jin-Oh Choi; Sang-Chol Lee; Ju Ryoung Moon; June Huh; I-Seok Kang; Heung Jae Lee
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.